Acessibilidade / Reportar erro

Respiratory complications in Brazilian patients infected with human immunodeficiency virus

Complicações respiratórias em pacientes brasileiros infectados pelo vírus da imunodeficiência humana

Abstracts

PURPOSE: To determine how often and by what means an indentifiable pulmonary pathogen can be recognized in human immunodeficiency virus (HIV) infected patients with respiratory disorders in Brazil, which are the most frequently observed microorganisms and what impact specific therapy has on these agents. PATIENTS AND METHODS: Thirty-five HIV seroposiüve subjects with respiratory complaints were studied. All patients had a complete history, physical examination and blood counts. The pulmonary assessment included chest radiograms; sputum examination for bacterial and fungal pathogens; bronchoscopy with bronchoalveolar lavage and transbronchial biopsy. Patients with treatable complications received standard antimicrobial therapy. RESULTS: One or more microorganisms were found in 24 subjects and another 3 individuals showed nonspecific interstitial pneumonitis. The sputum examination identified the pulmonary pathogens in 7 cases. The bronchoalveolar lavage and the histopathologic examination were diagnostic in 14% and 83%, respectively, of the 28 individuals that were submitted to bronchoscopy. The most frequently identified microorganism was P. carinii (55%), followed by M. tuberculosis (41%) and cytomegalovirus (8%). The clinical, laboratory and radiographic findings failed to distinguish the specific pulmonary pathogens. Twenty-three individuals with P. carinii pneumonitis and/or tuberculosis received specific therapy; among the evaluable patients the therapeutic response rates were 79% for PCP and 100% for TB. CONCLUSIONS: We have determined that tuberculosis, P. carinii and cytomegalovirus pneumonitis are the most common respiratory opportunistic diseases in Brazilian patients infected with HIV. The histologic evaluation was crucial in order to identify the pulmonary pathogens. Tuberculosis in AIDS individuals displayed clinical and radiographic findings atypical for reactivation disease. However, most of the features observed in HIV infected patients had been previously described in infection of the normal host. Furthermore, the AIDS subjects showed a good therapeutic response to anti-tuberculous drugs.

AIDS; HIV infection; Respiratory disorders; Tuberculosis; Pneumocystis carinii pneumonia; CMV pneumonitis; Nonspecific interstitial pneumonitis


OBJETIVO: Determinar a frequência e os meios pelos quais é possível identificar um agente patogênico respiratório em pacientes brasileiros infectados pelo vírus da imunodeficiência humana (HIV); quais são os microorganismos mais comuns; e qual é o impacto da terapêutica específica. PACIENTES E MÉTODOS: Trinta e cinco pacientes HIV positivos, com queixas respiratórias foram estudados. Todos os pacientes tiveram história, exame físico e testes hematólogicos. A avaliação da patologia respiratória incluiu radiografia pulmonar, exame do escarro para bactérias e fungos, broncoscopia com lavagem bronquiolo-alveolar e biopsia transbronquica. Pacientes com patologias tratáveis receberam a terapêutica indicada. RESULTADOS: Um ou mais organismos foram encontrados em 24 pacientes, e outros 3 pacientes mostraram pneumonite intersticial inespecífica. O exame de escarro identificou o agente patogênico pulmonar em 7 casos. O lavado bronquiolo-alveo-lar e o exame histopatológico definiram o diagnóstico em 14% e 83%, respectivamente, entre os 28 pacientes que foram submetidos à broncoscopia. O organismo mais comun foi P.carinii (55%), seguido por M.tuberculosis (41%), e citomegalovírus (8%). Os achados clínicos, laboratoriais e radioló-gicos não discriminaram os agentes patogênicos. Vinte e três pacientes com PCP ou tuberculose receberam terapêutica específica; entre os pacientes que puderam ser avaliados o tratamento foi bem sucedido em 79% dos episódios de PCP e 100% em TB. CONCLUSÕES: Determinamos que TB, PCP e CMV são as causas mais frequentes de infecções respiratórias em pacientes brasileiros infectados pelo HIV. O exame histológico foi essencial para firmar o diagnóstico etiológico. A TB em pacientes aidéticos assumiu formas semelhantes à TB primária em pacientes imunocompetentes e apresentou boa resposta terapêutica.


ORIGINAL ARTICLES

Respiratory complications in Brazilian patients infected with human immunodeficiency virus

Complicações respiratórias em pacientes brasileiros infectados pelo vírus da imunodeficiência humana

Adriana WeinbergI; Maria Irma Seixas DuarteII

IDepartment of Infectious Diseases of the "Hospital das Clínicas" of the University of São Paulo School of Medicine and Laboratory of Virology, Institute of Tropical Medicine, São Paulo, Brazil

IIDepartment of Pathology of the University of São Paulo School of Medicine. São Paulo, Brazil

Address for correspondence Address for correspondence: Adriana Weinberg, M.D. University Hospital School of Medicine Campus Box C227 4200 East Ninth Avenue Denver, Colorado 80262,U.S.A.

SUMMARY

PURPOSE: To determine how often and by what means an indentifiable pulmonary pathogen can be recognized in human immunodeficiency virus (HIV) infected patients with respiratory disorders in Brazil, which are the most frequently observed microorganisms and what impact specific therapy has on these agents.

PATIENTS AND METHODS: Thirty-five HIV seroposiüve subjects with respiratory complaints were studied. All patients had a complete history, physical examination and blood counts.

The pulmonary assessment included chest radiograms; sputum examination for bacterial and fungal pathogens; bronchoscopy with bronchoalveolar lavage and transbronchial biopsy. Patients with treatable complications received standard antimicrobial therapy.

RESULTS: One or more microorganisms were found in 24 subjects and another 3 individuals showed nonspecific interstitial pneumonitis. The sputum examination identified the pulmonary pathogens in 7 cases. The bronchoalveolar lavage and the histopathologic examination were diagnostic in 14% and 83%, respectively, of the 28 individuals that were submitted to bronchoscopy. The most frequently identified microorganism was P. carinii (55%), followed by M. tuberculosis (41%) and cytomegalovirus (8%). The clinical, laboratory and radiographic findings failed to distinguish the specific pulmonary pathogens. Twenty-three individuals with P. carinii pneumonitis and/or tuberculosis received specific therapy; among the evaluable patients the therapeutic response rates were 79% for PCP and 100% for TB.

CONCLUSIONS: We have determined that tuberculosis, P. carinii and cytomegalovirus pneumonitis are the most common respiratory opportunistic diseases in Brazilian patients infected with HIV. The histologic evaluation was crucial in order to identify the pulmonary pathogens. Tuberculosis in AIDS individuals displayed clinical and radiographic findings atypical for reactivation disease. However, most of the features observed in HIV infected patients had been previously described in infection of the normal host. Furthermore, the AIDS subjects showed a good therapeutic response to anti-tuberculous drugs.

Key words: AIDS; HIV infection; Respiratory disorders; Tuberculosis; Pneumocystis carinii pneumonia; CMV pneumonitis; Nonspecific interstitial pneumonitis.

RESUMO

OBJETIVO: Determinar a frequência e os meios pelos quais é possível identificar um agente patogênico respiratório em pacientes brasileiros infectados pelo vírus da imunodeficiência humana (HIV); quais são os microorganismos mais comuns; e qual é o impacto da terapêutica específica.

PACIENTES E MÉTODOS: Trinta e cinco pacientes HIV positivos, com queixas respiratórias foram estudados. Todos os pacientes tiveram história, exame físico e testes hematólogicos. A avaliação da patologia respiratória incluiu radiografia pulmonar, exame do escarro para bactérias e fungos, broncoscopia com lavagem bronquiolo-alveolar e biopsia transbronquica. Pacientes com patologias tratáveis receberam a terapêutica indicada.

RESULTADOS: Um ou mais organismos foram encontrados em 24 pacientes, e outros 3 pacientes mostraram pneumonite intersticial inespecífica. O exame de escarro identificou o agente patogênico pulmonar em 7 casos. O lavado bronquiolo-alveo-lar e o exame histopatológico definiram o diagnóstico em 14% e 83%, respectivamente, entre os 28 pacientes que foram submetidos à broncoscopia. O organismo mais comun foi P.carinii (55%), seguido por M.tuberculosis (41%), e citomegalovírus (8%). Os achados clínicos, laboratoriais e radioló-gicos não discriminaram os agentes patogênicos. Vinte e três pacientes com PCP ou tuberculose receberam terapêutica específica; entre os pacientes que puderam ser avaliados o tratamento foi bem sucedido em 79% dos episódios de PCP e 100% em TB.

CONCLUSÕES: Determinamos que TB, PCP e CMV são as causas mais frequentes de infecções respiratórias em pacientes brasileiros infectados pelo HIV. O exame histológico foi essencial para firmar o diagnóstico etiológico. A TB em pacientes aidéticos assumiu formas semelhantes à TB primária em pacientes imunocompetentes e apresentou boa resposta terapêutica.

Full text available only in PDF format.

Texto completo disponível apenas em PDF.

Recebido para publicação em 05/05/1992

Aceito para publicação em 11/01/1993

  • 1. ABOUYA, Y.L.; BEAUMEL, A.; LUCAS, S.; DAGOAKRIBI, A.; COULIBALY, G.; N'DHATZ, M.; KONAN, J.B.; YAPI, A. & DE COCK, K.M. - Pneumocystis carinii pneumonia . An uncommon cause of death in African patients with acquired immunodeficiency syndrome. Amer. Rev. resp. Dis., 145: 617-620, 1992.
  • 2. BIGBYT, T.D.; MARGOLESKEE, D.; CURTIS, J.L.; MICHAEL, P.F.; SHEPPARD, D.; HADLEY, W.K. & HOPEWELL, P.C. - The usefulness of induced sputum in the diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Amer. Rev. resp. Dis., 133: 515-518, 1986.
  • 3. BISHBURG, E.; SUNDERAM, G.; REICHMAN, L.B. & KAPILA, R. - Central nervous system tuberculosis with the acquired immunodeficiency syndrome and its related complex. Ann. intern. Med., 105: 210-213, 1986.
  • 4. BRAUN, M.M.; TRUMAN, B.I.; MAGUIRE, B.; DIFERDINANDO, G.T.; WORMSER, G.; BROADDUS, R. & MORSE, D.L. - Increasing incidence of tuberculosis in a prision inmate population. J. Amer. med. Ass., 261: 393-397, 1989.
  • 5. BROADDUS, C.; DAKE, M.D.; STULBARG, M.S.; BLUMENFELD, W.; HADLEY, W.K.; GOLDEN, J.A. & HOPEWELL, P.C. - Bronchoalveolar lavage and transbronchial biopsy for the diagnosis of pulmonary infections in the acquired immunodeficiency syndrome. Ann. intern. Med., 102: 747-752, 1985.
  • 6. CARCABA, B.; CARTON, J.A.; GARCIA, Z.; PALACIO, J.J.; MARADONA, J.A.; MUŃOZ, J.A. & ARRIBAS, J.M. - Differences among pulmonary (PT), extrapulmonary (ET), and disseminated tuberculosis (DT) in HIV-infected patients (abstract). In: INTERNATIONAL CONFERENCE on AIDS, 5., Montreal, 1989. Program and abstract. Montreal, 1989. p.209.
  • 7. CENTERS FOR DISEASE CONTROL - Tuberculosis and the acquired immunodeficiency syndrome - Florida. M.M.W.R., 35: 587-590, 1986.
  • 8. CENTERS FOR DISEASE CONTROL - Tuberculosis and the acquired immunodeficiency syndrome - New York city. M.M.W.R., 36: 785-795, 1987.
  • 9. CHAISSON, R.E. & HOPEWELL, P.C. - Empiric diagnosis of Pneumocystis pneumonia. J. Amer. med. Ass., 258: 3385, 1987.
  • 10. CHAISSON, R.E.; SCHECTER, G.F.; THEUER, C.P.; RUTHERFORD, G.W.; ENCHENBERG, D.F. & HOPEWELL, P.C. - Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical feature, response to therapy and survival. Amer Rev. resp. Dis, 136: 570-574, 1987.
  • 11. CHAISSON, R.E. & SLUTKIN, G. - Tuberculosis and human immunodeficiency virus infection. J. infect. Dis., 159: 96-100, 1989.
  • 12. CHEQUER, P.; LOURES, L.R.; CASTILHO, E. & BERGAMASHI, D. - Epidemiological approach of tuberculosis in AIDS patients - Brazil 1982 - 1988 (abstract). In: INTERNATIONAL CONFERENCE ON AIDS, 5., Montreal, 1989. Program and abstract. Montreal, 1989. p.197.
  • 13. CONTE, J.E.; HOLLANDER, H. & GOLDEN, J.A. - Inhaled or reduced-dose intravenous pentamidine for Pneumocystis carinii pneumonia. A pilot study. Ann. intern. Med., 107: 495-498, 1987.
  • 14. DREW, W.L. - Cytomegalovirus infection in patients with AIDS. J. infect. Dis., 158: 449-456, 1988.
  • 15. GOLDEN, J.A.; HOLLANDER, H.; CHERNOFF, D.; FEIGAL, D. & CONTE, J.E. - Prevention of Pneumocystis carinii pneumonia by inhaled pentamidine. Lancet, 1: 654-657, 1989.
  • 16. HAWKINS, C.C.; GOLD, J.W.M.; WHIMBLEY, E.; KIEHN, T.E.; BRANNON, P.; CAMMARATA, R.; BROWN, A.E. & ARMSTRONG, D. - Mycobacterium avium infections in patients with the acquired immunodeficiency syndrome. Ann. intern. Med., 105: 184-188, 1986.
  • 17. HOPEWELL, P.C. - Pneumocystis carinii pneumonia: diagnosis. J. infect. Dis., 157: 1115-1119, 1988.
  • 18. HUGHES, W.T. - Pneumocystis carinii pneumonitis. New Engl. J. Med., 317: 1021-1023, 1987.
  • 19. KOVACS, J.A.; HIEMENZ, J.W.; MACHER, A.M.; STOVER, D.; MURRAT, H.W.; SHELHANEN, J.; LANE, C.; URMACHER, C.; HONIG, C.; LONGO, D.C.; PARKER, M.M.; NATHANSON, C.; PARRILLO, J.E.; FAUCI, A.S.; PIZZO, P.A. & MANSUR, H. - Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann. intern. Med., 100: 663-671, 1984.
  • 20. MACFADDEN, D.K.; HYLAND, R.H.; INOUTE, T.; EDELSON, J.D.; RODRIGUEZ, C.H. & REBUCK, A.S. - Corticosteroids as adjunctive therapy in treatment of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Lancet, 1: 1477-1479, 1987.
  • 21. MICHALANY, J.; MATTOS, A.L.A.; FILIE, A.C. & MONTEZZO, L.C. - Acquired immune deficiency syndrome (ADDS) in Brazil. Necropsy findings. Ann. Path., 7: 15-24, 1987.
  • 22. MILLS, J. - Pneumocystis carinii and Toxoplasmosis in patients with AIDS. Rev. infect. Dis., 8: 1001-1011, 1986.
  • 23. MONTGOMERY, A.B.; LUCE, J.M.; TURNER, J.; LIN, E.T.; DEBS, R.J.; CORKERY, K.J.; BRUNETTE, E.N. & HOPEWELL, P.C. - Aerosolised pentamidine as sole therapy for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Lancet, 2: 480-483, 1987.
  • 24. MURRAY, J.F.; FELTON, C.P.; GARAY; S.M.; GOTTLIEB, M.S.; HOPEWELL, P.C.; STOVER, D.E. & TEIRSTEIN, A.S. - Pulmonary complications of the acquired immunodeficiency syndrome. Report of a National Heart, Lung and Blood Institute Workshop. New Engl. J. Med., 310: 1682-1688, 1984.
  • 25. MURRAY, J.F. & MILLS, J. - Pulmonary infectious complications of human immunodeficiency virus infection. Amer. Rev. resp. Dis., 141: 1356-1372, 1990.
  • 26. MURRAY, J.F.; GARAY, S.M.; HOPEWELL, P.C.; MILLS, J.; SNIDER, G.L. & STOVER, D.E. - NHLBI workshop summary. Pulmonary complications of the acquired immunodeficiency syndrome: an update. Report of the second National Heart, Lung and Blood Institute Workshop. Amer. Rev. resp. Dis., 135: 504-509, 1987.
  • 27. OGNIBENE, F.P.; MANSUR, H.; ROGERS, P.; TRAVIS, V.D.; SUFFREDINI, A.F.; FEUERSTEIN, E.; GILL, V.J.; BAIRD, B.F.; CARRASQUILLO, J.A.; PARRILLO, J.E.; LANE, H.C. & SHELHAMER, J.H. - Nonspecific interstitial pneumonitis without evidence of Pneumocystis carinii in asymptomatic patients infected with human immunodeficiency virus (HIV). Ann. intern. Med., 109: 874-879, 1988.
  • 28. PITCHENIK, A.E.; BURR, J.; SUAREZ, M.; FERTEL, D.; GONZALEZ, G. & MOAS, C. - Human T-cell lymphotropic virus-I11 (HTLV-III) seropositivity and related disease among 710, 1992.
  • 2. BIGBYT, T.D.; MARGOLESKEE, D.; CURTIS, J.L.; MICHAEL, P.F.; SHEPPARD, D.; HADLEY, W.K. & HOPEWELL, 875-879, 1987.
  • 29. PITCHENIK, A.E.; COLE, C.; RUSSELL, B.W.; FISCHL, M.A.; SPIRA, T.J. & SNIDER, D.E. - Tuberculosis, atypical mycobacteriosis and the acquired immunodeficiency syndrome among Haitian and non-Haitian patients in south Florida. Ann. intern. Med., 101: 641-645, 1984.
  • 30. PITCHENIK, A.E.; GANJEI, P.; TORRES, A.; EVANS, D.A.; RUBIN, E. & BAIER, H. - Sputum examination for the diagnosis of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Amer. Rev. resp. Dis., 133: 226-229, 1986.
  • 31. PITCHENIK, A.E. & RUBINSON, H.A. - The radiographic appearance of tuberculosis in patients with the acquired immune deficiency syndrome (AIDS) and Pre-AIDS. Amer. Rev. resp. Dis., 131: 393-396, 1985.
  • 32. QUINNAN, G.V.; MANSUR, H.; ROOK, A.H.; ARMSTRONG, G.; FREDERICK, W.R.; EPSTEIN, J.; MANISCHEWITZ, J.F.; MACHER, A.M.; JACKSON, L.; AMES, J.; SMITH, H.A.; PARKER, M.; PEARSON, G.R.; PARRILLO, J.; MITCHELL, C. & STRAUS, S. - Herpesvirus infections in the acquired immunodeficiency syndrome. J. Amer. med. Ass., 252: 72-77, 1984.
  • 33. REVISION of the case definition of acquired immunodeficiency syndrome. M.M.W.R., 36(suppl.): 1S-15S, 1987.
  • 34. SATTLER, F.R.; COWAN, R.; NIELSEN, D.M. & RUSKIN, J. - Trimethoprim-suifamethoxazole compared with pentamidine for the treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective noncrossover study. Ann. intern. Med., 109: 280-287, 1988.
  • 35. SELWYN, P.A.; HARTEL, D.; LEWIS, V.A.; SCHOENBAUM, E.E.; VERMUND, S.H.; KLEIN, R.S.; WALKER, A.T. & FRIEDLAND, G.H. - A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. New Engl. J. Med., 320: 545-550, 1989.
  • 36. SUFFREDINI, A.S.; OGNIBENE, F.P.; LACK, E.E.; SIMMONS, J.T.; BRENNER, M.; GILL, V.J.; LANE, H.C.; FAUCI, A.S.; PARRILLO, J.E.; MANSUR, H. & SHELHAMER, J.H. - Nonspecific interstitial pneumonitis: a common cause of pulmonary disease in the acquired immunodeficiency syndrome. Ann. intern. Med., 107: 7-13, 1987.
  • 37. SUGIMOTO, M.; NAKASHIMA, H.; MATSUMOTO, M.; UYAMA, E.; ANDO, M. & ARAKI, S. - Pulmonary involvement in patients with HTLV-I-associated myelopathy: increased soluble IL-2 receptors in bronchoalveolar lavage fluid. Amer. Rev. resp. Dis., 139: 1329-1335, 1989.
  • 38. SUNDERAM, G.; MACDONALD, R.J.; MANIATTS, T.; OLESKE, J.; KAPILA, R. & REICHMAN, L.B. - Tuberculosis as a manifestation of the acquired immunodeficiency syndrome (AIDS). J. Amer. med. Ass., 256: 362-366, 1986.
  • 39. TURCHI, M.D.; SUMITA, L.E. VILAS BOAS, L.S.; PANNUTI, C.S.; WEINBERG, A. & RIBEIRO, R.B. - Cytomegalovirus infections in AIDS patients: clinical, virological and histopathological correlations. Rev. Inst. Med. trop. S.Paulo, 33: 243-250, 1991.
  • 40. WHARTON, J.M.; COLEMAN, D.L.; WOFSY, C.B.; LUCE, J.M.; BLUMENFELD, W.; HADLEY, W.K.; INGRAM-DRAKE, L.; VOLBERDING, P.A. & HOPEWELL, P.C. - Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann. intern. Med., 105: 37-44, 1986.
  • 41. YOUNG, L.S. - Mycobacterium avium complex infection. J. infec. Dis., 157: 863-867, 1988.
  • 42. ZAMAN, M.K.; WOOTEN, B.S.; SUPRAHMANYA, B.; ANKOBIAH, W.; FINCH, P. & KAMHOLZ, S.L. - Rapid noninvasive diagnosis of Pneumocystis carinii from induced liquefied sputum. Ann. intern. Med, 109: 7-10, 1988.
  • Address for correspondence:

    Adriana Weinberg, M.D.
    University Hospital School of Medicine
    Campus Box C227
    4200 East Ninth Avenue
    Denver, Colorado 80262,U.S.A.
  • Publication Dates

    • Publication in this collection
      27 July 2006
    • Date of issue
      Apr 1993

    History

    • Received
      05 May 1992
    • Accepted
      11 Jan 1993
    Instituto de Medicina Tropical de São Paulo Av. Dr. Enéas de Carvalho Aguiar, 470, 05403-000 - São Paulo - SP - Brazil, Tel. +55 11 3061-7005 - São Paulo - SP - Brazil
    E-mail: revimtsp@usp.br